welbournes

The Department of Health and Social Care (DHSC) has issued a medicine supply notification for the following product: Betamethasone 500microgram soluble tablets sugar free MSN/2025/040 Tier 2 – medium impact Date of issue: 30/06/2025 Betamethasone 500microgram soluble tablets are out of stock until late July 2025, when a limited resupply is expected; full resupply is [...]

The post Medicine Supply Notification: Betamethasone 500microgram soluble tablets sugar free appeared first on Community Pharmacy England.

The Department of Health and Social Care (DHSC) has today (19/06/2025) confirmed the following initial list of price concessions for June 2025: Drug Pack size Price concession Alfuzosin 2.5mg tablets 60 £6.21 Amiodarone 200mg tablets 28 £2.39 Betamethasone 500microgram soluble tablets sugar free 100 £36.00 Clarithromycin 125mg/5ml oral suspension 70 £6.08 Clarithromycin 250mg/5ml oral suspension 70 [...]

The post June 2025 Price Concessions 1st Update appeared first on Community Pharmacy England.

Department of Health and Social Care (DHSC) has issued a medicine supply notification for NovoRapid® PumpCart® (insulin aspart) 100units/ml solution for injection 1.6ml cartridges. MSN/2025/034 Tier 2 – medium impact Date of issue: 4th June 2025 NovoRapid® PumpCart® (insulin aspart) 100units/ml solution for injection 1.6ml cartridges are in limited supply until 2027 and cannot support [...]

The post Medicine Supply Notification: NovoRapid® PumpCart® (insulin aspart) 100units/ml solution for injection 1.6ml cartridges appeared first on Community Pharmacy England.

The following price concession granted in May 2025 has rolled over to June 2025: Drug Pack size May 2025 price concession Fluticasone 400microgram/unit dose nasal drops 30 £17.22 Please note any rolled over prices can be adjusted upwards if we receive reports from pharmacy owners to indicate suppliers’ selling prices have increased. The review can [...]

The post Rolled over price concession for June 2025 appeared first on Community Pharmacy England.

MHRA Class 4 Medicines Notification: Various Products (Zentiva Pharma UK Limited) Date issued: 2 June 2025 Zentiva Pharma UK Limited has informed the MHRA that the batches of soluble or effervescent tablets listed in the annexes are taking longer than expected to fully dissolve, resulting in an increase in residual material being observed. Additionally, some [...]

The post MHRA Class 4 Medicines Notification Various Products (Zentiva Pharma UK Limited) appeared first on Community Pharmacy England.